---
layout: minimal-medicine
title: Copanlisib
---

# Copanlisib
### Generic Name
Copanlisib

### Usage
Copanlisib is a targeted therapy used to treat relapsed follicular lymphoma (FL) in adults.  This means it's prescribed for patients whose FL has returned after at least two previous systemic treatments (treatments that affect the whole body).  It's specifically designed to target certain proteins involved in the growth and survival of lymphoma cells.  Currently, Copanlisib is not approved for use in other cancers or conditions.

### Dosage
Copanlisib is administered intravenously (IV). The standard dosage for adults with relapsed follicular lymphoma is 60 mg given on days 1, 8, and 15 of a 28-day treatment cycle.  Treatment continues until the disease progresses or unacceptable side effects occur.

**Dosage Adjustments:**  The dose may need adjusting based on several factors:

* **Hepatic Impairment:** For patients with mild liver impairment, no dose adjustment is typically necessary.  Moderate impairment may require a dose reduction to 45 mg.  For those with severe liver impairment, dosage adjustments are not specifically defined in the prescribing information and should be discussed with a healthcare provider.
* **Renal Impairment:** For patients with a creatinine clearance (CrCl) of at least 15 mL/min, dosage adjustments are not routinely recommended.  However, for CrCl less than 15 mL/min or end-stage renal disease, dosage adjustments aren't specified in the manufacturer's labeling and should be determined in consultation with a physician.
* **Toxicity Management:** Dose adjustments or treatment interruptions are frequently necessary due to side effects. These adjustments are based on specific side effects such as neutropenia (low white blood cell count), thrombocytopenia (low platelet count), dermatologic toxicity (skin reactions), hyperglycemia (high blood sugar), and hypertension (high blood pressure).  The prescribing information provides detailed guidelines on how to manage these toxicities and adjust the Copanlisib dose accordingly.  This should only be performed under the close supervision of a healthcare professional.


**Pediatric Use:** The safety and effectiveness of Copanlisib have not been established in children.

### Side Effects
Copanlisib can cause several side effects, some common and others less frequent but potentially more serious.

**Common Side Effects (>10%):**

* Fatigue
* Hypertension (high blood pressure)
* Diarrhea
* Nausea
* Increased serum lipase (a pancreatic enzyme)
* Stomatitis (mouth sores)
* Vomiting
* Skin rash
* Hyperglycemia (high blood sugar)
* Hypertriglyceridemia (high triglycerides)
* Hypophosphatemia (low phosphate levels)
* Hyperuricemia (high uric acid levels)
* Decreased hemoglobin (anemia)
* Leukopenia (low white blood cell count)
* Decreased absolute lymphocyte count
* Neutropenia (low neutrophil count)
* Thrombocytopenia (low platelet count)
* Lower respiratory tract infection


**Less Common but Serious Side Effects (1-10% or less, including post-marketing reports):**

* Severe hyperglycemia
* Severe neutropenia
* Pneumonitis (lung inflammation)
* Pneumonia
* Exfoliative dermatitis (severe skin reaction)
* Serious infections (including potentially fatal *Pneumocystis jirovecii* pneumonia)


**Important Note:** This is not an exhaustive list.  If you experience any concerning side effects, contact your healthcare provider immediately.

### How it Works
Copanlisib is a kinase inhibitor, specifically targeting phosphatidylinositol-3-kinase (PI3K) isoforms alpha and beta.  These isoforms are often overactive in follicular lymphoma cells. By inhibiting PI3K, Copanlisib disrupts several key signaling pathways crucial for lymphoma cell growth, survival, and spread. This ultimately leads to the death of lymphoma cells (apoptosis) and inhibits their proliferation.

### Precautions
* **Drug Interactions:** Copanlisib's metabolism is affected by certain other drugs.  Strong CYP3A4 inducers can decrease Copanlisib levels, while strong CYP3A4 inhibitors can increase them, potentially leading to increased toxicity. Discuss all medications you are taking with your doctor or pharmacist before starting Copanlisib. Avoid grapefruit juice and St. John's Wort while on this medication.
* **Pregnancy and Breastfeeding:** Copanlisib can harm a developing fetus.  Women of reproductive potential should use effective contraception during treatment and for at least one month after the last dose.  Breastfeeding is not recommended during and for at least one month after Copanlisib treatment.
* **Infections:**  Copanlisib increases the risk of serious infections, including *Pneumocystis jirovecii* pneumonia (PCP).  Your doctor may recommend preventative measures.
* **Other Warnings:**  Copanlisib can also increase the risk of non-infectious pneumonitis, hyperglycemia, hypertension, and severe skin reactions.  Regular monitoring is crucial to detect and manage these potential complications.


### FAQs

* **Q: How is Copanlisib stored?** A:  Refer to the specific storage instructions provided with your medication.

* **Q: What should I do if I miss a dose?** A: Contact your doctor or healthcare provider immediately.  Do not attempt to make up a missed dose on your own.

* **Q:  Can I take other medications with Copanlisib?** A: Discuss all medications, supplements, and herbal remedies with your doctor or pharmacist before starting Copanlisib. Some interactions can be dangerous.

* **Q:  What are the long-term effects of Copanlisib?** A:  Long-term effects are not fully understood and require ongoing monitoring by your healthcare provider.

* **Q: Are there any specific dietary restrictions while taking Copanlisib?** A: Avoid grapefruit juice and St. John's wort, as they can affect how the drug works in your body. Your doctor may provide additional dietary advice based on your individual health needs and side effects.  Regular monitoring of blood glucose levels may also be necessary.

**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice.  Always consult with your healthcare provider or pharmacist for any questions about your medications, including Copanlisib.  They can provide personalized guidance based on your medical history and current health status.
